HMD ships 140 million KOJAK AD syringes order for global Covid vaccination campaigns

New Delhi: Hindustan Syringes & Medical Devices (HMD) has shipped the last shipment of 35 million pieces of KOJAK Auto Disable Syringes to Covax stockpile facility via UNICEF to complete the 140 million KOJAK AD Syringes order for 2020 stockpiled AD Syringes for global Covid vaccination campaigns.

“Yesterday, 29^th December 2020 was our last of the 35 million pcs shipment to COVAX facility via UNICEF to complete our 140 million pcs orders for 2020 stockpiled AD Syringes for global Covid vaccination campaigns. HMD, as committed, delivered a total of 140 million in 5 months’ time to the Covax facility working for global equitable access to COVID-19 vaccines,” said Mr. Rajiv Nath, Managing Director, HMD.

“Similarly on Monday, 28^th December 2020, we got inspected the last batch of the 83.5 million pcs order that we got from Govt. of India for 0.5 ml AD Kojak Syringes for vaccination including for Covid as scheduled and committed and today on 30^th December 2020 we plan to ship the last of 60.03 million pcs for which we have received the laboratory test results of the 83.5 million pcs PO in anticipation of the vaccination roll out in India in January,” stated Rajiv Nath.

HMD is the leading 4 suppliers of AD Syringes to UNICEF and the largest manufacturer in India of Auto Disable Syringes that ensure one injection from one syringe and recipients are assured a safe injection that’s not been used earlier.

“In anticipation of the unprecedented spike in demand, HMD from an annual capacity of 0.5 ml Kojak AD syringes of 560 million pcs in June has ramped up to over 700 million pcs p.a. currently which we plan to increase to 800 million pcs per annum in 1st Qtr of 2021 & then 1000 million pcs per annum in 2nd Qtr of 2021 as India gets ready for COVID-19 Vaccine. If Govt. enters into a supply long term contract we can plan to produce more.” Said Mr. Nath.

 According to Mr. Rajiv Nath, the estimated demand in India would be around 900 million pieces of different kinds of syringes for just one shot of the vaccine, considering 60-70 per cent of the country gets vaccinated. The number would amplify to 1.8 billion if the vaccine India chooses needs two shots.

HMD is currently producing approximately 1 lakh pcs of 0.5 ml Kojak AD syringes per hour, 24 hours a day – it’s going to be a challenge to vaccinate over 1.5-2 lakh people every hour in 8 working hours daily . By April – June we will need to build infrastructure to vaccinate over 2-2.5 lakh people per hour i.e 16 to 20 lakh people daily.

With over 9 plants, HMD has created a niche for their disposable syringe ―DISPOVAN which is today the most popular brand in the syringe market in India with over 60% market share with Dispovan Needle and Dispovan Insulin Syringes having over 70% Market Share and thereby displaced renowned MNC‘s – an inspirational case study for other Indian entrepreneurs.

HMD is one of the largest suppliers to UN Agencies like UNICEF, UNOPS for Auto Disable Syringes for immunization and is also the first Company in India to manufacture Auto Disable Syringes for Curative Segment.